体肺分流术治疗儿童重度肺动脉高压的国际注册研究
该回顾性国际注册研究纳入欧洲和美国13家中心的110例接受体肺分流术的肺动脉高压患儿,术后院内死亡17例(15%),出院后93例中18例死亡或接受肺移植(20%),平均随访3.1年。出院患儿1年和5年免于死亡或移植率分别为92%和68%,WHO功能分级、6分钟步行距离和BNP均显著改善,59%完全停用前列环素输注。术前需ICU、机械通气或ECMO是院内死亡的危险因素。
要点
- 体肺分流术可使重度肺动脉高压患儿获得持久临床改善,部分可停用前列环素。
- 出院患儿1年和5年免于死亡或移植率分别为92%和68%。
- 术前需ICU、机械通气或ECMO者院内死亡风险高,不宜行分流术。
核心结论
- 体肺分流术可为重度肺动脉高压患儿带来显著且持久的临床改善,并可能免除持续前列环素输注。
- 患儿5年生存率与因肺动脉高压接受肺移植的儿童相当。
- 术前存在严重失代偿需强化监护治疗者不是分流术的良好候选。
研究设计与样本
- 回顾性数据来自欧洲和美国13家机构,共纳入110例接受体肺分流术的肺动脉高压患儿。
主要发现
- 术后院内死亡17例(15%)。
- 93例成功出院回家,其中18例后续死亡或接受肺移植(20%),平均随访3.1年(范围25天至17年)。
- 总体1年和5年免于死亡或移植率分别为77%和58%,出院患儿分别为92%和68%。
- 出院患儿WHO功能分级(P < 0.001)、6分钟步行距离(P = 0.047)显著改善,BNP水平显著降低(P < 0.001)。
- 术后59%的患儿完全停用前列环素输注(P < 0.001)。
关键数值与推荐
- 院内死亡术前危险因素:ICU入住(HR 3.2;P = 0.02)、机械通气(HR 8.3;P < 0.001)、ECMO(HR 10.7;P < 0.001)。
临床怎么用
- 对于重度肺动脉高压患儿,体肺分流术可作为肺移植前的姑息治疗选择,可能减少持续静脉前列环素依赖。
- 术前需评估患儿是否处于严重失代偿状态,需ICU、机械通气或ECMO者应谨慎选择分流术。
局限性
- 回顾性研究设计。
- 样本量相对较小(110例)。
- 随访时间范围差异大(25天至17年)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The placement of a pulmonary-to-systemic arterial shunt in children with severe pulmonary hypertension (PH) has been demonstrated, in relatively small studies, to be an effective palliation for their disease. OBJECTIVES: The aim of this study was to expand upon these earlier findings using an international registry for children with PH who have undergone a shunt procedure. METHODS: Retrospective data were obtained from 110 children with PH who underwent a shunt procedure collected from 13 institutions in Europe and the United States. RESULTS: Seventeen children died in-hospital postprocedure (15%). Of the 93 children successfully discharged home, 18 subsequently died or underwent lung transplantation (20%); the mean follow-up was 3.1 years (range: 25 days to 17 years). The overall 1- and 5-year freedom from death or transplant rates were 77% and 58%, respectively, and 92% and 68% for those discharged home, respectively. Children discharged home had significantly improved World Health Organization functional class (P < 0.001), 6-minute walk distances (P = 0.047) and lower brain natriuretic peptide levels (P < 0.001). Postprocedure, 59% of children were weaned completely from their prostacyclin infusion (P < 0.001). Preprocedural risk factors for dying in-hospital postprocedure included intensive care unit admission (hazard ratio [HR]: 3.2; P = 0.02), mechanical ventilation (HR: 8.3; P < 0.001) and extracorporeal membrane oxygenation (HR: 10.7; P < 0.001). CONCLUSIONS: A pulmonary-to-systemic arterial shunt can provide a child with severe PH significant clinical improvement that is both durable and potentially free from continuous prostacyclin infusion. Five-year survival is comparable to children undergoing lung transplantation for PH. Children with severely decompensated disease requiring aggressive intensive care are not good candidates for the shunt procedure.
引用
- Grady RM, Canter MW, Wan F, et al. Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension. J Am Coll Cardiol. 2021. PMID: 34325836. doi:10.1016/j.jacc.2021.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。